We recently reported interaction of a polymorphism with microRNA binding and downregulation of target gene expression as well as their correlation with tumor size and lymph node infiltration in estrogen receptor (ER)-negative breast cancer (Anwar et al., 2017). The gene discussed is ESR1; the disease is breast cancer.